Dr. Sarah Chen -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Sarah Chen, a Psychiatry physician based in Fort Lauderdale, FL. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Sarah Chen has received $1,252.02 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Sarah Chen has received a total of $1,252.02 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $1,252.02 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Sarah Chen's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Travel & Lodging$1,252.02Transportation and hotel expenses for conferences and meetings

The largest payment category for Dr. Sarah Chen is Travel & Lodging, accounting for 100% ($1,252.02) of total pharmaceutical payments received. This represents the primary type of financial relationship between Dr. Sarah Chen and pharmaceutical companies.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Sarah Chen. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Biogen$1,252.021

Dr. Sarah Chen has a financial relationship with Biogen, receiving $1,252.02 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Sarah Chen. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Sarah Chen's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Sarah Chen has received $1.3K across 1 pharmaceutical payments as a Psychiatry physician in Fort Lauderdale, FL. Top paying companies include Biogen ($1.3K). Dr. Chen received a single payment of $1252 in 2025, totaling her entire reported pharma payment history. The payment was exclusively for travel expenses, with no other payment types reported. Biogen was the sole company to make a payment to Dr. Chen, representing 100% of her total reported payments.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Sarah Chen is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

When reviewing a physician's payment history, consider the total amount, the number and types of payments, and the companies involved to understand potential influences. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Sarah Chen Compares to Other Psychiatry Physicians

For Psychiatry specialists, payment profiles often show a wider range of payment types and sources, reflecting diverse interactions with pharmaceutical companies.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Sarah Chen in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Biogen$1,252.02travelFarxiga2025-12-30Not Assessed

Frequently Asked Questions About Dr. Sarah Chen's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Sarah Chen received?

Sarah Chen has received a total of $1.3K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Sarah Chen taking too much pharma money?

Sarah Chen has received $1.3K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Psychiatry), the types of payments, and how they compare to peers. The largest payment category is travel ($1.3K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Sarah Chen?

The top pharmaceutical companies paying Sarah Chen are: Biogen ($1.3K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Sarah Chen receive?

Sarah Chen's payments by type: travel: $1.3K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Sarah Chen's payments compare to other Psychiatry doctors?

To compare, look at the total amount ($1.3K), number of payments (1), and the types of payments received. Psychiatry physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Sarah Chen's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1220124625). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Sarah Chen's pharma payment profile?

The entirety of Dr. Chen's reported pharma payments comes from a single source (Biogen) and is categorized under a single payment type (travel). Sarah Chen has received $1.3K in total pharma payments.

How does Sarah Chen compare to peers in Psychiatry?

For Psychiatry specialists, payment profiles often show a wider range of payment types and sources, reflecting diverse interactions with pharmaceutical companies.

Are Sarah Chen's pharma relationships typical for Psychiatry?

The payment is linked to a specific drug, Farxiga, though the nature of the travel expense in relation to this drug is not detailed.

What should patients of Sarah Chen know about these payments?

When reviewing a physician's payment history, consider the total amount, the number and types of payments, and the companies involved to understand potential influences.

What patterns are visible in Sarah Chen's payment history?

The data reflects a very limited snapshot, with only one payment recorded for the year 2025.

Understanding This Doctor Payment Report

This transparency report for Dr. Sarah Chen is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Sarah Chen's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Sarah Chen and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.